John Peter Mclaughlin is Director of PDL BIOPHARMA, INC.. Currently has a direct ownership of 200,000 shares of PDLI, which is worth approximately $496,000. The most recent transaction as insider was on Dec 22, 2020, when has been sold 277,934 shares (Common Stock) at a price of $2.61 per share, resulting in proceeds of $725,408. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 200K
0% 3M change
0% 12M change
Total Value Held $496,000

JOHN PETER MCLAUGHLIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 22 2020
SELL
Open market or private sale
$725,408 $2.61 p/Share
277,934 Reduced 58.15%
200,000 Common Stock
Dec 21 2020
SELL
Open market or private sale
$131,000 $2.62 p/Share
50,000 Reduced 9.47%
477,934 Common Stock

Also insider at

LNSR
LENSAR, Inc. Healthcare
RMTI
ROCKWELL MEDICAL, INC. Healthcare
JPM

John Peter Mclaughlin

Director
Orlando, FL

Track Institutional and Insider Activities on PDLI

Follow PDL BIOPHARMA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PDLI shares.

Notify only if

Insider Trading

Get notified when an Pdl Biopharma, Inc. insider buys or sells PDLI shares.

Notify only if

News

Receive news related to PDL BIOPHARMA, INC.

Track Activities on PDLI